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We have previously reported that rats are resilient to the hepatotoxic andlethal combination of
chlordecone (CD) and carbon tetrachloride (CC14) during early postnatal development. The
overall findings pointed to stimulated cell division and tissue repair mechanisms as theunderly-
ig cause ofresistance. The objective ofthe current swudy was to investigate ifthe antimitotic
efifect of colchicine (CLC) abolishes this resiliency to CD + CCI4 by inhibing ongoing and
stimulated cell division.We used 45-day-old rats in this study because this age group exhibited
partial sensitivityto CD + CCI4 in ourprevious studies. Male Sprague-Dawley rats were treated
withasingle lowintraperitoneal doeofCC14 (100 p111k) or corn oilafterexosure to either 10
ppm CD in the diet or anormal diet (ND) for 15 days. CLC (1 mg/ki) was administered 6 or
30 hr after CCO4 to ND or CD rats, respectively. Adminisation ofCLC resulted in increased
CCI4-inducedmortalityfrom 25% to 85% in rats pretreatedwith CD, in contrast to 100% SUr-
vival in ND rats. Liver injury was assesed byplasma alanine transaminase (ALTO and sorbitol
dehydrogenase (SDH) elevations as wefl as by histopathology. Hepatoceilular regeneration was
assessed by3H-thymidine (3H-lT) incorporation into hepatonudear DNA and proliferating cell
nudear antigen (PCNA) studies during 0-96 hr after CCI4.Administration of CLC to ND +
CC14 rats resulted in a slightdelayin celldivision and tissue repair, as indicated by3H-T incor-
poration and PCNA, thereby leading toprolongedlr injury as aled by elevations in plas-
ma ALT, SDH, and histpatological lesions. In contrast, CLC administration to CD + CC14-
treated rats fiutherdelayed anddiminishedcell division by80%, which ledto unretained pro-
gresion ofCCI4-inducedliver injury, resulting in 85% mortality.Thesefindings underscore the
importance ofongoing and toxicant-stimulated cell division and tissue repair meanisms in
hepatotoxidty, and the need for the inclusion ofage factors in risk assessment ofexposure to
environmental and other chemicals. Key words. carbon tetrachloride, chlordecone, colchicine,
postnatal resiliency, tissue repair. Environ Health Ppect 106:597-606 (1998). [Online 17
August 19981
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Previous studies demonstrated that chemi-
cal-induced hepatic injury and disease can
either increase or decrease with age (1).
Recent studies have revealed that neonates
and young rats are resilient to awide variety
of structurally and mechanistically dissimi-
lar hepatotoxicants such as CC14 (2-6), allyl
alcohol (7), galactosamine (8), and aceta-
minophen (9). Furthermore, young rats are
resilient to the combination ofchlordecone
(CD) and CC14 (4-6), which is known to
cause fulminant hepatic failure (10) and
100% mortality in adult rats (10-12).
Carbon tetrachloride is a hepatotoxic
halomethane capable of causing hepatocel-
lular fatty degeneration and centrilobular
necrosis (13,14). The widely accepted
mechanism of CC14-initiated liver injury
involves the bioactivation of CCl4 by the
cytochrome P450-mediated reactions to the
'CC13 free radical, which is further convert-
ed to a peroxy radical, CC130I (15). These
free radicals readily react with polyunsatu-
rated fatty acids to initiate lipid peroxida-
tion. In the presence ofcellular 02, peroxy
radicals in turn can react with other
polyunsaturated fatty acids to perpetuate a
series of self-propagating chain reactions
that lead to runaway lipid peroxidation. It
is well documented that stimulation of
hepatocellular regeneration and tissue
repair mechanisms play a critical role in
recovery from the limited liver injury
inflicted by a low dose ofCCl4 (100 pl/kg)
(16,17). Prior exposure to a nontoxic dose
of CD (10 ppm in diet for 15 days) is
known to amplify hepatotoxicity and lead
to lethality by a low dose CC14 (100 pl/kg)
in adult rats (10-12). Studies have revealed
that the CD + CCl4 combination inhibits
CCl4-induced liver cell division and tissue
repair in part through the depletion of
hepatocellular energy, thereby permitting
progression of injury leading to hepatic
failure and animal death (11,12,17-23).
Earlier studies have suggested that new-
borns are less sensitive to chemicals like
CCl4 because of lower cytochrome P450
levels required for the bioactivation ofCCl4
to a toxic species (2,3,9). However, recent
3H-T incorporation and proliferating cell
nuclear antigen (PCNA) studies indicate
that younger rats (45 days old) exhibit
resiliency not only to CCl4 alone, but also
to the lethal combination of CD and CC14.
This resiliency was closely associated with
enhanced plasticity in hepatocellular regener-
ation and efficient tissue repair mechanisms
in the younger animals (4-6), rather than
due to differences in cytochrome P450 levels
or bioactivation-dependent mechanisms (4).
Furthermore, young rats are also resilient to
hepatotoxicants such as galactosamine,
which do not depend on cytochrome P450
bioactivation to inflict liver injury (8). These
studies indicate that timely and efficient cell
division are the key events in the resiliency of
younger rats to hepatotoxicants.
The time-course studies (4-6) revealed
that the loss of resiliency in adult rats may
be due to insufficient cell proliferation and
tissue repair, leading to unrestrained pro-
gression of injury rather than infliction of
more severe injury. Ifcell division is respon-
sible for the resiliency exhibited by postna-
tally developing rats, then inhibition ofcell
division by antimitotic agents (e.g.,
colchicine) should lead to a progression of
CCl4-induced hepatotoxicity and lethality.
Therefore, the objective of the present
study was to investigate ifintervention with
cell division and tissue repair by the antimi-
totic colchicine abolishes the resiliency of
postnatally developing rats to CC14 and CD
+ CC14 hepatotoxicity and lethality. We
report here that mitotic intervention signifi-
cantly diminishes the resiliency of postna-
tally developing rats to CC14 toxicity. The
findings ofthis study underscore the critical
role ofcell division and tissue repair in the
final outcome ofhepatic injury during early
postnatal development. Most importantly,
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from a public health perspective (in partic-
ular child health), the results of this study
may suggest consideration of a new para-
digm in risk assessment and management
ofexposure to a mixture ofenvironmental
chemicals.
Materials and Methods
Animals. Postnatally developing (30-day-
old) male Sprague-Dawley rats were
obtained from our Central Animal
Facilities and were maintained under con-
trolled conditions of temperature (200C
±1), relative humidity (50-80%), and illu-
mination (12 hr light, 12 hr dark). All rats
had free access to commercial powdered
food (4% crude fat rat/mouse diet #7001,
Teklad, Indianapolis, IN) and water. All
animal husbandry and handling conditions
were according to the Institutional Animal
Care and Use Committee guidelines.
Treatment. Rats were maintained on
the standard rodent powdered diet with
(CD) or without (ND) 10 ppm CD for 15
days as described by Curtis and Mehendale
(19). On day 16 (when the rats turned 45
days old), rats from each dietary protocol
were challenged with a single intraperi-
toneal (ip) dose of CCl4 (100 pl/kg) or
corn oil. Blood and liver samples were col-
lected at 0, 6, 12, 24, 36, 48, 72, and 96 hr
after CCl4 or corn oil administration. The
blood samples were used to determine plas-
ma alanine transaminase (ALT) and sor-
bitol dehydrogenase (SDH), whereas the
liver samples were used to determine 3H-T
incorporation into hepatic nuclear DNA
(see below for pulse-labeling studies), for
histopathology, and for PCNA analyses.
Colchicine (CLC; 1 mg/kg) was adminis-
tered in normal saline (NS) to ND and CD
rats at 6 and 30 hr after CC14 administra-
tion, respectively. Colchicine was adminis-
tered 6 hr before the maximum stimulation
(12 hr for ND and 36 hr for CD) ofDNA
synthesis as assessed by3H-T incorporation
studies in both ND + CCl4 and CD +
CCl4 treatment groups. Similarly, blood
and liver samples were obtained during a
time-course of0-96 hr for biochemical and
pathological studies. Colchicine at 1 mg/kg
has been shown to have no measurable
effects on the metabolism, disposition of
CC14, or function ofthe liver (23).
Assessment ofliver injury. We mea-
sured plasma enzymes ALT (EC 2.6.1.2)
and SDH (EC 1.1.1.14) as markers ofliver
injury according to the methods of
Bergmeyer et al. (24) and Asada and
Galambos (25), respectively. This analysis
was corroborated byhepatopathology using
10% formalin-fixed, paraffin embedded, 5-
pm thick sectioned tissues, stained with
hematoxylin and eosin (H&E) (26).
Assessment ofhepatocellularprolifera-
tion. We measured hepatic cell prolifera-
tion using 3H-T incorporation into hepa-
tonuclear DNA and PCNA techniques.
3H-thymidine was administered at a dose
of 50 pCi/300 g body weight (ip) 2 hr
before sacrifice. The procedure used to iso-
late hepatonuclear DNAwas that described
by Chang and Looney (27). Briefly, 1 g of
liver sample was homogenized in 20 w/v
2.2 M sucrose solution at 40C. The
homogenates were centrifuged at 40,000g
for 1 hr in a Beckman L5-75 ultracen-
trifuge (Beckman Instruments, Palo Alto,
CA). The sedimented nuclei were washed
twice with 0.25 M sucrose. To 1 ml of
nuclear suspension we added 0.5 ml of
0.6N perchloric acid (PCA) and centifuged
at 10,000g for 20 min. The nuclear con-
tent was ultimately suspended in 6 ml of
0.5 N PCA and centrifuged at 10,000gfor
20 min. Liver DNA content was measured
by diphenylamine reaction as described by
Burton (28). To 1 ml of extracted DNA
solution, 2 ml of diphenylamine reagent
was added and incubated at room tempera-
ture for 16-18 hr. DNA content was deter-
mined spectrophotometrically at 600 nm.
Two aliquots of200 pl-ofthe DNA super-
natants were added to 10 ml Scientiverse-E
to quantify radioactivity using a Packard
scintillation counter (Packard Instrument
Company, Meriden, CT).
The PCNA study was conducted as
described by Greenwell et al. (29). Briefly,
formalin-fixed livertissueswereprocessed for
paraffin embedding. Liver sections (5-pm
thick) weremounted onpoly-L-lysine-treated
slides, deparaffinized, and subjected to 3%
H202 to quench endogenous peroxide activ-
ity.Tissueswere blockedwith 0.5% casein to
suppress nonspecific binding ofIgG. Liver
sections were then incubated with mono-
clonal primary antibody to PCNA (Dako
Corp., Carpentaria, CA), linked with
biotinylated goat anti-mouse IgG antibody
(Boehringer/Mannheim, Indianapolis, IN),
and labeled with streptavidin-conjugated
Table 1. Effects ofcolchicine antimitosis on lethalityofCD + CCI4combination in45-day-old ratsa
Group Treatment n % Lethality % Survival
I ND+CO+CLC 10 0 100
11 ND +CCI4 + NS 10 0 100
Ill ND + CCI4+ CLC 10 0 100
IV CD + CCI4 + NS 20 25 75
V CD+CCI4+CLC 20 85 15
WMale Sprague-Dawley rats were maintained on either normal diet(ND) or 10 ppm chlordecone (CD) inthe dietfor 15days. On day 16, a non-
toxic dose of carbon tetrachloride (CC14) (100 pi/kg, ip) was administered in corn oil (CO) to all rats. Rats maintained on ND and those main-
tained on CD received colchicine (CLC) at 6 hr prior to maximum S-phase stimulation induced by CCd4 (100 pVkg, ip). The animals were
observed twice dailyfor 14days. All deaths in CD + CCI4 + NS-treated rats occurred between 36 and 72 hr,whereas in CD + CC14 + CLC-treat-
ed rats, it occurred between 36 and 96 hr after administration ofCC14. NS, normal saline.
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Figure 1. Effects of colchicine (CLC) antimitosis on plasma alanine transaminase (ALT) in rats maintained
on normal diet(ND)with orwithout carbontetrachloride (CCI )treatment. The rats received CLC (1 mg/kg,
ip) 6 hr before S-phase stimulation after administration of &14 (100 pi/kg, ip). Plasma ALT levels were
monitored during a time-course after CCd4 (100 pi/kg, ip) administration to 45-day-old rats maintained on
ND. Values are expressed as means ± standard errors offour rats.
*Significantincrease in ALT levels as compared tothe respective control [ND + corn oil (CO) + CLC] ofsametime point.
'Significantly higherALTlevels compared tothat in ND + CC14 + normal saline (NS) rats (p<0.05).
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peroxidase Jackson Immunoresearch, West
Grove, PA). Color was developed by 3,3'-
diaminobenzidine, and cells were counter-
stained with hemotoxylin (Sigma, St. Louis,
MO). Cells in various phases ofthe cycle were
identified as follows:Go, cells with no staining;
G1, cells with light brown nudear staining; S,
cells with deep brown nuclear staining; G2,
cells with diffuse speckled nudear staining and
brown cytoplasmic staining; and M, cells with
diffuse cytoplasmic staining with deep blue
chromosomal staining. Quantitation of the
various cell cycles were conducted using Leica's
computer image analyzer Q 500MC (Leica,
Deerfield, IL).
Statisticalanalysis.The data are present-
ed as mean ± standard error of the mean
(SEM). We used two-way analysis ofvari-
ance followed by pairwise comparisons of
selected means using the pooled within-
group variance comparisons. The criterion
forsignificance was set atp<0.05.
Results
Lethality study. The lethality study was
conducted to examine if stimulated cell
division is critical in the resiliency ofpost-
natally developing rats to CD-potentiated
CCl4 hepatotoxicity and lethality. This
concept was tested in 45-day-old rats using
CLC antimitosis because this age group is
known to exhibit partial sensitivity (25%
mortality) to CD + CCl4 (4,5). The
administration ofCLC (1 mg/kg, ip) to the
ND + CCl4 group did not result in any
mortality (Table 1). In contrast, CLC
increased the mortality from 25% to 85%
in 45-day-old CD + CCl4- treated rats.
Assessment ofhepatic injury. Plasma
ALT and SDH were measured in 45-day-
old rats as markers of liver injury 12, 24,
36, 48, 72, and 96 hr after the administra-
tion of CC14. Treatment with CCI4 alone
resulted in transient and marginal liver
injury as evidenced by ALT elevation at 12
hr (Fig. 1) and SDH elevation (notshown).
Thereafter, liver injury declined, leading to
complete recovery by 48 hr. Suppression of
stimulated cell division by CLC adminis-
tered 6 hr after CCl4 treatment resulted in
elevation ofplasma ALT level as early as 12
hr, peaking at 36 hr (Fig. 1). Recovery from
CCl4-inflicted liver injury was evident by
48 hr after CC14. Thus, the limited and
transient liver injury caused by a low dose
ofCCl4 alone was increased in the presence
ofCLC treatment.
Pretreatment with CD dramatically
amplified CCl4-induced liver toxicity as evi-
denced by plasma enzyme levels. Adminis-
tration ofCCI4 to CD-pretreated 45-day-old
rats resulted in significant elevation ofplas-
maALT (Fig. 2) and SDH (data notshown)
as early as 6 hr after the administration of
CC14. Enzyme elevation progressed with
time, with the peak occurring 36 hr after
CCI4. Injury was sustained until 48 hr, after
which enzyme levels declined to control lev-
els by 96 hr. The progression ofliver injury
was accompanied by 25% mortality, which
occurred between 36 and 72 hr after CCl4.
Administration of CLC to the CD + CCI4
group resulted in persistence ofALT eleva-
tions noted at 36 and 48 hr. In contrast to
the CD + CCl4 group, enzyme elevations
were persistent even at 72 and 96 hr (Fig. 2).
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Figure 2. Effects of colchicine (CLC) antimitosis on plasma alanine transaminase (ALT) in rats maintained on
10 ppm chlordecone (CD) dietfor 15 days. The rats received CLC (1 mg/kg, ip) 6 hr before S-phase stimulation
induced by carbon tetrachloride (CCI4; 100 pi/kg, ip). Plasma ALT levels were measured during a time-course
after CCI4(100 pi/kg, ip) administration. Values are expressed as means ± standard errors offour rats.
*Significant increase in ALT levels as compared tothe corresponding control [CD + corn oil(CO) +CLC] ofthe sametime point
"Significantly higherALT levels compared to CD + CCI4 + normal saline(NS) rats(p<0.05).
This sustenance in injury was concomitant
with increased mortality (85%, which
occurred between 36 and 96 hr after CCl4)
noted in the CD + CCl4 + CLC group,
compared to the 25% mortality noted in the
CD + CCl4 + NS group.
Histopathological alterations were
assessed in liver sections bylightmicroscopy
for necrotic, swollen (ballooned), and lipid-
laden hepatocytes (Figs. 3 and 4). Histo-
pathological changes were consistent with
theplasma enzyme elevations. Irrespective of
pretreatment, CCl4-induced liver injury was
evident around the centrilobular region as
early as 6 hr after CC14 treatment. The
injuryprogressed with time, as evidencedby
the extent ofpyknotic nuclei and swollen,
lipid-laden hepatocytes. No histopathologi-
cal alterations were evident in the livers of
control rats (0 hr timepoint: Figs. 3A,B and
4A,B) regardless ofdietary treatment.
In ND rats, CCl4-induced liver injury
was evident as early as 6 hr after CC14
administration, with the maximum injury
at 12 hr (Fig. 3C), followed by recoveryby
48 hr (Fig. 3E). Administration ofCLC to
ND + CCl4-treated rats resulted in more
severe and prolonged liver injury, although
it did not affect recovery from CC14-
induced liver injury (Fig. 3D). Similarly,
CCl4-induced liver injury in CD-pretreated
rats was evident as early as 6 hr after CC14
administration. However, injury progressed
with time, with maximum injury observed
at 48 hr (Fig. 4C), until 25% mortality
occurred within 72 hr. The morphological
alterations in the livers of the surviving
75% of45-day-old rats were minimal at 96
hr after the administration of CCl4 (Fig.
4E). In contrast, liver injury in CD + CC14
+ CLC rats was higher than in ND + CC14
+ CLC- or CD + CCl4 + NS-treated groups
(Fig. 4D). Furthermore, the rate ofrecovery
from liver injury in CD + CCl4 + CLC-
treated rats (15% survivors) was delayed
(Fig. 4F) compared to that seen in the 75%
survivors of CD + CCI4 + NS treatment
group (Fig. 4E), with incomplete recovery
even at 96 hrafterCC14 administration.
Effects ofcolchicine on carbon tetra-
chloride-induced cell division. We used
CLC to examine whether intervention of
mitosis in the CD + CCl4 rats decreased
cell division and whether this correlated
with increased mortality. In ND + CCl4
rats, significant increases in 3H-T incorpo-
ration occurred between 12 and 36 hr after
the administration of CCl4 (Fig. 5).
However, administration of CLC resulted
in blockage of S-phase stimulation at 12
and 24 hr, the maximum 3H-T incorpora-
tion being shifted from 12-24 hr to 36 hr
after the administration of CC14 (Fig. 5).
This delay in cell division in ND + CCl4 +
Environmental Health Perspectives Volume 106, Number 9, September 1998
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CLC-treated rats correlated with increased
liver injury (Fig. 1).
In sharp contrast, the CD + CC14 + NS
treatment resulted in significantly delayed
S-phase stimulation as evidenced by the
3H-T incorporation (Fig. 6). Consequently,
maximum S-phase stimulation occurred at
72 hr compared to that occurring between
12 and 36 hr in the ND + CC14 + NS
group (Fig. 5). The 75% survival in the CD
+ CC14 + NS treatment group is concordant
with this substantial increase in tissue repair
that occurred between 36 and 72 hr after
CC14.Administration ofCLC to the CD +
CC14 group resulted in a marked suppres-
sion of S-phase synthesis (Fig. 6).
Administration of CLC resulted in an
80% decrease in the maximum 3H-T
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Figure 3. Representative photomicrograph oftypical H&E-stained liver section from 45-day-old rats challenged with a single dose of carbon tetrachloride (CCI4; 100
pi/kg, ip). (A) Normal diet (ND) + CC14 + normal saline (NS) at zero time point. (B) ND + CCI4 + colchicine (CLC) at zero time point. (C) Time of maximum injury(12 hr
after CC14) in the ND + CCI4 + NS group. (D) Time of maximum injury(48 hr after CC14) in the ND + CCI4 + CLC group. (E) Time of recovery(48 hr afterCCd4) inthe ND +
CCI4 + NS group. (F)Time ofrecovery(48 hr afterCCI4) inthe ND + CCI4 + CLC group. xl12. Abbreviations: C, central vein; S, swollen and vacuolated cells.
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incorporation in CD + CCl4-treated rats at
72 hr after CC14 (Fig. 6).
The PCNA immunohistochemical
staining was conducted to corroborate the
findings in the 3H-T incorporation study.
This technique enables one to identify cells
in various phases of the cell cycle. The
PCNA study demonstrated a similar hepa-
tocellular proliferative activity pattern as
observed in the 3H-T incorporation study.
In control rats (zero time), almost all the
cells were in the resting phase (Go) of the
cell cycle (Figs. 7A,B and 8A,B). Only
about 3% of the total hepatocytes were in
S-phase (Tables 2 and 3).
A significant number ofcells progressed
to G1 and S-phase ofthe cell cycle by 12 hr
after CC14 in ND + CC14 + NS rats. A
Figure 4. Representative photomicrograph of typical H&E-stained liver section from 45-day-old rats maintained on 10 ppm chlordecone (CD) diet for 15 days. On
day 16, they were challenged with a single dose of carbon tetrachloride (CCI4; 100 pi/kg, ip). (A) CD + CCI4 + normal saline (NS) at zero time point. (B) CD + CCd4 +
colchicine (CLC) at zero time point. (C) Time of maximum injury (48 hr after CCI4) in the CD + CC14 + NS group. (D) Time of maximum injury (72 hr after CCI4) in the
CD + CCI4 + CLC group. (E) Time of recovery(96 hr after CC14) in the CD + CCI4 + NS-treated surviving rats (75%). (F) Time of partial recovery(96 hr after CCI4) in the
CD + CCI4 + CLC-treated surviving rats (15%). xl12. Abbreviations: C, central vein; N, necrosis; L, lipid-laden cells.
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Figure 5. Effects of colchicine (CLC) antimitosis on 3H-thymidine incorporation in 45-day-old rats main-
tained on normal diet (ND). The rats received CLC (1 mg/kg, ip) 6 hr before S-phase stimulation after
administration of carbon tetrachloride (CC14; 100 pI/kg, ip). 3H-Thymidine incorporation was measured dur-
ing a time-course of 0-96 hr after CCI4' Values are expressed as means ± standard errors of four rats.
*Significantly highervalue as compared tothe respective control group(0hr).
#Significantly highervalue as compared to ND +CCI4 + normal salineINS) rats atthe corresponding time point.
tSignificantly highervalue compared to ND + corn oil(CO) + CLC rats atthe corresponding time point. (p.0.05).
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Figure 6. Effects of colchicine (did) antimitosis on 3H-thymidine incorporation in 45-day-old rats main-
tained on 10 ppm chlordecone (CD) diet for 15 days. The rats received CLC (1 mg/kg, ip) 6 hr before S-
phase stimulation induced by carbon tetrachloride (ddl4; 100 p1/kg, ip). 3H-Thymidine incorporation was
measured during a time-course after dCI4. Values are expressed as means + standard errors of four rats.
*Significantly highervalue as compared totheir control group (0 hr).
#Significantly lowervalue as compared to CD +CCI4+ normal salineINS) rats atthe corresponding time point(p.005).
maximum number ofcells were seen in S-
phase (about 20%) between 24 and 36 hr
after CC14 (Table 2 and Fig. 7C). These
results are consistent with peak 3H-T
incorporation during the same time point
(Fig. 5). Administration of CLC to ND +
CC14-treated rats resulted in a significant
reduction ofcells in S-phase (from 20% to
about 2%) 24 hr after the administration
ofCC14 (Table 2 and Fig. 7D). In contrast,
in CD-pretreated rats, a significant increase
in G1 (10.3%) and S-phase (7.2%) cells
occurred as early as 6 hr after CC14, the
maximum in S-phase being noted at 72 hr
(about 70%) after CC14 (Table 3 and Fig.
8C). By 96 hr, the proliferative activity of
the hepatocytes was still above the back-
ground (Table 3). CLC administration to
CD + CC14-treated rats resulted in signifi-
cant reduction of cells in S-phase from
68% to 21% at 72 hr, a reduction byabout
47%, compared to those treated with CD
+ CC14 + NS (Table 3 and Fig. 8D). Cell
division (M-phase) needed for tissue repair
was reduced in the CD + CC14 + CLC
group during the same time point (Table
3). These findings are concordant with the
3H-T pulse-labeling studies.
Discussion
In infants and children exposed to environ-
mental toxicants, risk may differ qualita-
tively and quantitatively from adults for a
number of reasons, including physiology,
metabolism, pharmacokinetics, diet, and
physical environment (30,31). Infants and
children may be more sensitive or less sen-
sitive depending on the target organ and
the chemicals to which they are exposed.
Moreover, because these processes can
change rapidly and can counteract one
another, there is no simple way to predict
the kinetics and sensitivity to chemical
compounds in infants and children from
data derived entirely from adult humans or
from toxicity testing in adults and young
animals (32,33).
It is well established that liver injury ini-
tiated by exposure to a single low dose of
CC14 (100 pl/kg, ip) results in stimulation
of hepatocellular proliferation and tissue
repair mechanisms, which occur as an
endogenous compensation in response to
the limited liver injury inflicted by CC14.
This compensatory response permits recov-
ery from injury and survival of animals
(11,12,17,34-36). It is also known that
exposure to a combination ofCD and CC14
results in suppression ofthis compensatory
tissue repair in rats, allowing progression of
liver injury, culminating in liver failure and
animal death (10-12,17,34-36). In con-
trast, young rats are resilient to CD-potenti-
ated CC14 hepatotoxicity and lethality pri-
marily because ofongoing liver cell division
replacing dead or dying cells, thereby sup-
pressing the progression of liver injury
(4-6). Furthermore, liver injury inflicted by
a low dose ofCC14 results in additional and
timely stimulation ofcell division over and
above ongoing liver growth (4-6). This in
turn allows restoration of hepatolobular
structure and function in the liver. Both of
these events (CCI4-stimulated cell division
and ongoing liver growth) provide protec-
tion to younger rats against CD-potentiated
CC14 hepatotoxicity and lethality during
postnatal development.
Ifcell division and tissue repair are crit-
ical determinants of the resiliency of post-
natally developing rats, then blocking cell
division by antimitotic agents should lead
to prolonged and unrestrained progression
of liver injury, ultimately leading to
increased mortality. Forty-five-day-old rats
experienced 25% lethality upon exposure
tO CD + CC-4. If stimulated cell division
and tissue repair are critical events for the
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Figure 7. Immunohistochemical localization of proliferating cell nuclear antigen (PCNA) during a time-course after carbon tetrachloride (CCI4; 100 p1/kg, ip) adminis-
tration to 45-day-old rats maintained on normal (ND) diet. A group of rats [ND + CCI4 + colchicine (CLC)] received CLC (1 mg/kg, ip) before S-phase stimulation
induced by CCI4 (100 p1/kg, ip). (A) ND + CCI4 + normal saline (NS) at zero time point. (B) ND + CCI4 + CLC at zero time point. (C, 0) Time atwhich maximum number of
cells were seen in S, G2, and M phases ofthe cell cycle for ND + CCI4 + NS (24 hr after CCI4) and ND + CCI4 + CIC (36 hr after CCI4) groups, respectively. (For details
see Table 2.) Got cells with no staining; G1, cells with light brown nuclear staining; S, cells with deep brown nuclear staining; G2, cells with or without speckled
nuclear staining and brown cytoplasmic staining; and M, cells with diffused cytoplasmic staining and with deep blue chromosomal staining. x281.
resiliency of 75% of the surviving rats,
intervening with cell division should lead
to higher lethality in this group. Colchicine
is an antimitotic agent often used in
manipulation of cell division (23,37,38).
Tsukamoto and Kojo (39) reported that
CLC inhibits S-phase DNA synthesis by
inhibiting thymidine kinase and thymidy-
late synthetase enzymes responsible for
DNA synthesis. Colchicine is also known
to disrupt cell division by preventing prop-
er assembly ofmicrotubules in the mitotic
spindle (40). Colchicine at a dose of 1
mg/kg is an effective antimitotic agent with
no measurable side effect (37,38) or any
influence on the metabolism and disposi-
tion ofCC14 (23). In 45-day-old rats, treat-
ment with CCl4 alone resulted in limited
liver injury, which goes through the pro-
gressive phase up to 12 hr with subsequent
recovery via stimulation of tissue repair,
leading to restoration ofthe damaged tissue
with no lethal consequence. Colchicine
antimitosis in this group (administered 6
hr after CC14) results in selective inhibition
of the early phase of hepatic cell division
after a low dose of CC14 (23). Because of
inhibited early phase stimulation of cell
division, the limited liver injury inflicted
by CC14 is increased, as evidenced by plas-
ma ALT (Fig. 1) and SDH elevations.
However, significant cell division that
occurs at later time points leads to com-
plete recovery from liver injury.
Colchicine intervention in CD + CC14
rats resulted in even more accelerated pro-
gression ofliver injury, which led to signifi-
cantly higher lethality. Colchicine blocked
DNA synthesis and cell division, leading to
diminished and delayed hepatocellular
regeneration and tissue repair in CD +
CCl4-treated rats. This was evidenced by
80% reduction in 3H-T incorporation
compared to CD + CC14 + NS-treated rats
(Fig. 6). A similar pattern can also be seen
at 72 hr after CC14 with PCNA studies,
where CLC treatment resulted in about
47% reduction of cells in S-phase of cell
cycle compared to those treated with CD +
CC14 + NS (Table 3). Consequently, liver
injury progressed in an unrestrained man-
ner. Persistence ofliver injury coupled with
insufficient tissue repair led to hepatic fail-
ure in a majority of the 45-day-old rats
receiving CD + CC14 + CLC treatment.
This resulted in increased lethality from
25% to 85% (Table 1), with all deaths
occurring by 96 hr after the administration
ofCC14. Highly accelerated progression of
liver injury upon CLC administration is
evident from persistent plasma enzyme lev-
els and is corroborated by histopathology.
The survival of 15% of the rats is presum-
ably due to a much higher tissue repair, as
indicated by higher DNA synthesis at 72
and 96 hr (Table 3, Figs. 6 and 8). Another
study by Rao et al. (41), in which
dose-response relationship between liver
injury and compensatory tissue repair were
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Figure8. Immunohistochemical localization ofproliferating cell nuclearantigen (PCNA) during a time-course after carbontetrachloride (CCI * 100 pi/kg, ip) adminis-
tration to45-day-old rats maintained on 10 ppm chlordecone (CD) dietfor 15days. A group of rats [CD + CCI4 + colchicine(CLC)1 receivedCLt(1 mg/kg,ip) before S-
phase stimulation induced by CCI4(100 pi/kg, ip). (A) CD + CCI4 + normal saline (NS) at zero time point. (B) CD + CCI4 + CLC at zero time point. (C, D) Time atwhich
maximum number of cells were seen in S, G2, and M phase for CD + CCI4 + NS and CD + CCI4 + CLC, respectively(72 hr after CCI4for both groups). (For details see
Table 3.) GO' cells with no staining; G1, cells with light brown nuclearstaining; S, cells with deep brown nuclearstaining; G2, cells with orwithoutspeckled nuclear
staining and brown cytoplasmic staining; and M, cellswith diffused cytoplasmic staining andwith deep blue chromosomalstaining. x281.
examined in CCl4-treated adult male rats,
supports the critical role ofcell division and
tissue repair in animal survival. In this study,
administration of a high dose ofCC14 (4
ml/kg) consistently resulted in 20% survival.
Examination ofS-phase stimulation (3H-T
incorporation) and cell cycle progression
(PCNA) revealed a five-fold increase in
DNA synthesis in this small population of
the survivors. This massive increase in DNA
synthesis appeared to faciitate efficient tissue
repair processes, enabling 20% survival of
rats. This was presumably due to genetic
variation in these outbred rats. Therefore,
the resiliency to the lethal combination of
CD + Cd4 + CLC in asmall number ofrats
is to beanticipated.
The overall results ofthis study indicate
that 45-day-old rats maintained on ND
fully recover from liver injury inflicted by
CC14 (100 pl/kg) owing to combined com-
pensatory effects of ongoing cell division,
additional stimulation of hepatocellular
regeneration, and restoration ofhepatolobu-
lar architecture. Administration of CLC to
the ND + CC14 group results in an increase
in the limited injury. This transient increase
in injury does not seem to affect recovery
rate of the rats from CCl4-inflicted liver
injury. Treatment with CLC alone resulted
in aslight increase in theALTvalue at 12 hr
(Fig. 1). A similar pattern ofALT values
were reported by Rao and Mehendale (23).
The slight increase in ALT values between
12 and 24 hr in rats receiving CLC did not
translate to any noticeable liver necrosis.
The same dose of CC14 in CD-treated 45-
day-old rats leads to some decrease in com-
pensatory response, resulting in 25% mor-
tality. However, 75% of 45-day-old rats
escape death from this lethal combination of
CD and CCl4 owing to ongoing liver
growth and additional stimulation of cell
division and tissue repair mechanisms.
Mitotic intervention with CLC further
decreased the survival in CD + CCl4-treated
rats from 75% to 15% (Table 1), which
demonstrates the critical role of ongoing
liver growth and stimulation ofhepatocellu-
lar regeneration in the resiliency of postna-
tally developing rats to the lethal combina-
tion ofCD andCCI4.
Toxicity resulting from exposure to two
or more chemicals at individually nontoxic
doses is of great interest from the public
health viewpoint because this exposure sce-
nario is most common (35,36,42,43). The
current EPA risk assessment procedures use
a safety factor of 10 to account for popula-
tion variability. Infants and children are not
routinely included in risk assessment, and
most environmental regulations are based
on exposure data of adult males (33,44).
These concerns led the U.S. Congress in
1988 and recent years to request the
National Academy of Sciences/National
Research Council to carefully examine this
issue (32). A better understanding ofwhy
infants and children respond differently to
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Table 2. Hepatocytes in different phases of cell cycle during a time course afterCCI4 in rats treated with
ND + CCI4+ NS or ND +CCI4+CLC
Percentage of cells in different phases of cell cyclea
Hours after CCI4 Go G1 S G2 M
ND + CCI4 + NS
0 86.1 (1.55) 9.4(1.08) 3.5(0.75) 0.7 (0.18) 0.4(0.11)
6 70.9 (1.1)* 17.9 (0.7)* 8.5 (0.29)* 2.3 (0.25)* 0.6 (0.12)*
12 57.2 (3.84)* 22.1 (1.29)* 16.7 (0.94)* 3.2 (0.21)* 0.8 (0.07)*
24 55.5 (2.05)* 23.9 (2.34)* 19.9 (0.15)* 0.6 (.035) 0.2 (0.10)*
36 73.8(5.27)* 10.2 (1.18)* 15.7 (1.20)* 0.2 (0.09)* 0.2 (0.05)*
48 92.3(0.52)* 3.4(0.33)* 4.2(1.27) 0.1 (0.06)* 0.1 (0.04)*
72 76.8(2.66)* 20.5(1.44)* 2.6(1.18) 0.2(0.03)* 0.04 (0.04)*
96 79.1 (6.45) 13.6 (3.72) 5.6(0.85)* 0.0 (0.00)* 1.8(0.14)*
ND + CCI4 + CLC
12 88.1 (5.82)# 5.9 (0.46)*# 5.1 (0.22)*# 0.4(0.09)*# 0.6(0.31)*
24 90.9(4.10)# 7.6 (0.70)*# 1.6 (0.69)*# 0.0 (0.00)*# 0.0(0.00)*#
36 71.1 (2.24)* 15.3 (0.8)*# 9.3 (1.56)*# 1.7 (0.07)*# 2.6 (0.21)*#
48 93.9(5.99)* 3.8(1.37)* 2.2(1.74)# 0.0(0.00)*# 0.1 (0.04)*
72 89.7 (1.99)# 5.6 (1.02)*# 3.6 (0.76) 0.6 (0.16)*# 0.6 (0.10)*#
96 93.9 (3.09)# 4.6 (0.22)*# 1.4 (0.12)*# 0.0 (0.00)* 0.04 (0.03)*#
Abbreviations: CCI4, carbon tetrachloride; ND, normaldiet; NS, normal saline; CLC, colchicine.
aPercentage was calculated from 1,000 cells counted from five randomly selected fields per slide. Forty-five-day-old male Sprague-Dawley
rats received a single nontoxic dose of CCI4 (100 pi/kg, ip) in corn oil In=4). In a second group, CLC (1 mg/kg, ip in NS) was injected 6 hr after
CCi4. Values are means ± SE(in parentheses). Controls for eachtime pointwere notsignificantly differentfrom zerotime.
*Significantly differentfrom control zerotime (p<0.05).
#Significantly differentfromthe ND + CCi4 + NS group ofthe sametime point(p.e0.05).
Table 3. Hepatocytes in different phases of cell cycle during a time course afterCCI4 in rats treated with
CD + CCI4 + NS or CD + CCI4 + CLC
Percentage of cells in different phases of cell cyclea
Hours after CC14 Go Gi S G2 M
CD + CCI4+ NS
0 93.4(2.55) 3.7 (0.95) 2.8(0.12) 0.1 (0.05) 0.0(0.00)
6 80.2(2.32)* 10.3 (0.37)* 7.2(1.58)* 2.1 (0.33)* 0.1 (0.04)*
12 79.2(1.05)* 20.8(2.07)* 10.5(3.94)* 0.1 (0.05) 0.0(0.00)
24 63.2(3.13)* 16.6(2.03)* 19.9 (4.46)* 0.1 (0.00) 0.02(0.01)*
36 71.1 (4.67)* 11.5 (0.81)* 17.4(1.07)* 0.0(0.00)* 0.0(0.00)
48 54.6(2.52)* 8.4 (1.17)* 37.1 (2.53)* 0.0(0.00)* 0.0 (0.00)
72 12.3(3.01)* 4.5 (0.80) 67.6(5.09)* 11.3 (1.46)* 4.4(0.20)*
96 19.5(1.47)* 16.4(3.29)* 49.3(2.57)* 8.7(0.46)* 6.1 (0.32)*
CD + CCI4 + CLC
36 86.6(1.90)*# 8.9(3.94)* 4.4(1.39)*# 0.0 (0.00)* 0.0(0.00)
48 71.3(0.35)*# 19.4 (0.88)*# 6.8(0.83)*# 1.5(0.44)*# 0.9 (0.17)*#
72 35.5(2.80)*# 33.9(1.95)*# 21.1 (0.56)*# 2.1 (0.06)*# 1.3(0.18)*#
96 42.0 (5.23)*# 39.9(4.51)*# 15.9(3.45)*# 1.3(0.07)*# 0.9(0.08)*#
Abbreviations: CCI4, carbontetrachloride; ND, normal diet; NS, normal saline; CLC, colchicine; CD, chlordecone.
sPercentage was calculated from 1000 cells counted from five randomly selected fields per slide In = 41. Forty-five-day-old male Sprague-
Dawley rats were challenged with low dose ofCC14 1100 pi/kg, ip1 in corn oil following dietary CD (10 ppml for 15 days. In a second group, CLC
(1 mg/kg, ip in normal saline) was administered 30 hr after CC14. Values are means ± SE (in parentheses). Controls for each time point were
notsignificantly different from zerotime.
*Significantly differentfrom control zero time (p50.05).
#Significantly different fromthe CD + CC14 + NS group ofthe sametime point(p50.05).
environmental chemicals is dearly needed.
The findings of this study shed some light
on the importance ofthe tissue repair factor
in the resiliency ofyounger rats to hepato-
toxicants. Furthermore, these findings sup-
port the inclusion of age factors in risk
assessment ofpesticides and other environ-
mental chemicals. In the context of liver
injury from toxic chemicals, our present
findings suggest that liver injury is initiated
by well-established mechanisms. Liver
injury is restrained from progression due to
greater stimulation of tissue repair in the
young rats. Consequently, younger rats are
able to overcome liver injury and restore
liver structure and function. In the livers of
younger animals, compensatory tissue
repair response to injury is prompt, presum-
ably because of facilitatory humoral factors
and more efficient tissue repair due to
shorter time for cell cycle completion (6).
The molecular mechanisms underlying this
expedient and efficient tissue repair at
younger ages areworthy ofinvestigation.
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